vimarsana.com

Latest Breaking News On - Silvia siegfried schanz - Page 1 : vimarsana.com

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates.

Maria grazia alderuccioErich hunzikerKrogsgaard thomsenThomas eggerPearl huangClive meanwellEssa pharmaCamilla soenderbyClaude mikkelsenLaura hamillSilvia siegfried schanzNeurocrine biosciencesTanja chicherioAgios pharmaceuticalsAlnylam pharmaceuticalsGeneration bio co

BB Biotech AG publishes its 2023 annual report

EQS-Ad-hoc: BB BIOTECH AG / Key word: Annual Report/Dividend BB Biotech AG publishes its 2023 annual report 16-Feb-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article.

Maria grazia alderuccioClaude mikkelsenTanja chicherioThomas eggerSilvia siegfried schanzUte communicationsAnnual general meetingGrazia alderuccio

EQS-Adhoc: BB Biotech AG publishes its 2023 annual report - adhoc - Börsennachrichten

EQSAdhoc BB BIOTECH AG Key word Annual ReportDividend BB Biotech AG publishes its 2023 annual report 16Feb2024 0700 CETCEST Disclosure of an inside information acc to Article 17 MAR of the Regulation

Tanja chicherioMaria grazia alderuccioClaude mikkelsenThomas eggerSilvia siegfried schanzUte communicationsAnnual general meetingGrazia alderuccio

Investor interest returns – dividend yield remains high for 2024

EQS-News: BB BIOTECH AG / Key word: Dividend Investor interest returns – dividend yield remains high for 2024 14.02.2024 / 07:00 CET/CEST The issuer is solely.

Silvia siegfried schanzThomas eggerMaria grazia alderuccioClaude mikkelsenTanja chicherioInvestment management teamUte communicationsAnnual general meetingIntra cellular therapies phaseGrazia alderuccioBellevue asset management

BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle -January 19, 2024 at 01:02 am EST

EQS-News: BB BIOTECH AG / Key word: Annual Results/Dividend BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle 19.01.2024 / 07:00.

Erich hunzikerSilvia siegfried schanzThomas eggerEssa pharmaNeurocrine biosciencesTanja chicherioClaude mikkelsenCamilla soenderbyMaria grazia alderuccioAgios pharmaceuticalsVertex pharmaceuticalsAlnylam pharmaceuticalsCelldex therapeuticsNovo advisory groupBaloise holdingUte communications

vimarsana © 2020. All Rights Reserved.